Screener
Pasithea Therapeutics KTTA Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$0.16In line
Revenue estimate$300.0K
EPS estimate-$0.16
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did Pasithea Therapeutics report Q2 2026 earnings?
- Pasithea Therapeutics (KTTA) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were Pasithea Therapeutics's Q2 2026 revenue and EPS?
- Pasithea Therapeutics reported eps of $-0.16 for Q2 2026.
- Did Pasithea Therapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.16 by $0.00.
- How did Pasithea Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 75.8% from $-0.66.
- Where can I find Pasithea Therapeutics's Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001213900-26-090146) directly on SEC EDGAR. The filing index links above go to sec.gov.
